Correlation Between VistaGen Therapeutics and Verrica Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both VistaGen Therapeutics and Verrica Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VistaGen Therapeutics and Verrica Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VistaGen Therapeutics and Verrica Pharmaceuticals, you can compare the effects of market volatilities on VistaGen Therapeutics and Verrica Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VistaGen Therapeutics with a short position of Verrica Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of VistaGen Therapeutics and Verrica Pharmaceuticals.
Diversification Opportunities for VistaGen Therapeutics and Verrica Pharmaceuticals
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between VistaGen and Verrica is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding VistaGen Therapeutics and Verrica Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verrica Pharmaceuticals and VistaGen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VistaGen Therapeutics are associated (or correlated) with Verrica Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verrica Pharmaceuticals has no effect on the direction of VistaGen Therapeutics i.e., VistaGen Therapeutics and Verrica Pharmaceuticals go up and down completely randomly.
Pair Corralation between VistaGen Therapeutics and Verrica Pharmaceuticals
Given the investment horizon of 90 days VistaGen Therapeutics is expected to generate 0.29 times more return on investment than Verrica Pharmaceuticals. However, VistaGen Therapeutics is 3.39 times less risky than Verrica Pharmaceuticals. It trades about -0.1 of its potential returns per unit of risk. Verrica Pharmaceuticals is currently generating about -0.09 per unit of risk. If you would invest 306.00 in VistaGen Therapeutics on September 25, 2024 and sell it today you would lose (56.00) from holding VistaGen Therapeutics or give up 18.3% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
VistaGen Therapeutics vs. Verrica Pharmaceuticals
Performance |
Timeline |
VistaGen Therapeutics |
Verrica Pharmaceuticals |
VistaGen Therapeutics and Verrica Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with VistaGen Therapeutics and Verrica Pharmaceuticals
The main advantage of trading using opposite VistaGen Therapeutics and Verrica Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VistaGen Therapeutics position performs unexpectedly, Verrica Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verrica Pharmaceuticals will offset losses from the drop in Verrica Pharmaceuticals' long position.VistaGen Therapeutics vs. Fate Therapeutics | VistaGen Therapeutics vs. Caribou Biosciences | VistaGen Therapeutics vs. Arcus Biosciences | VistaGen Therapeutics vs. Karyopharm Therapeutics |
Verrica Pharmaceuticals vs. Oric Pharmaceuticals | Verrica Pharmaceuticals vs. Lyra Therapeutics | Verrica Pharmaceuticals vs. Inhibrx | Verrica Pharmaceuticals vs. ESSA Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |